Bionic Eye Maker Second Sight Sets Terms For $32 Million IPO

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Second Sight Medical Products, which markets camera-based retinal implants that restore some vision to the blind, filed and set terms for its IPO on Tuesday. The Sylmar, CA-based company plans to raise $32 million by offering 3.5 million shares at $9.00 per share. At the proposed price, Second Sight would command a fully diluted market value of $326 million.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC